Have an attendance code? Sign In to enter it.
2022 Fall Focused Symposium: Accelerating Translation of Tissue Engineering and Regenerative Medicine Technologies in the Dental, Oral, and Craniofacial Space
There have been significant strides in research in regenerative approaches to the repair and restoration of dental, oral, and craniofacial (DOC) tissues, ranging from bone graft materials to regenerative endodontics to temporomandibular joint repair. Yet few regenerative medicine therapies in the DOC space have been commercialized and widely adopted clinically. Difficulties in translation are related to scientific as well as non-scientific challenges. This symposium will highlight innovative tissue engineering/ regenerative medicine research in the DOC space, as well as layout the roadmap for overcoming challenges and translating technologies to the marketplace.
Learning Objectives
There have been significant strides in research in regenerative approaches to the repair and restoration of dental, oral, and craniofacial (DOC) tissues, ranging from bone graft materials to regenerative endodontics to temporomandibular joint repair. Yet few regenerative medicine therapies in the DOC space have been commercialized and widely adopted clinically. Difficulties in translation are related to scientific as well as non-scientific challenges. This symposium will highlight innovative tissue engineering/ regenerative medicine research in the DOC space, as well as layout the roadmap for overcoming challenges and translating technologies to the marketplace.
Learning Objectives
- Attendees will increase their knowledge of cutting-edge regenerative medicine approaches to a variety of clinical challenges in the DOC space.
- Attendees will increase their understanding of the technology commercialization pathway, from academic research to clinical trials to commercialization and beyond, including regulatory requirements and market development.
- Attendees will be provided with an armamentarium of tools to approach translation of tissue engineering/ regenerative medicine research to the marketplace and beyond.
Time (EST) | Presentation |
---|---|
2:00 p.m. |
Welcome Back Jaques Nör, Donald A. Kerr Endowed Professor of Dentistry and Chair of the Department of Cariology, Restorative Sciences and Endodontics, University of Michigan School of Dentistry, Immediate Past President, AADOCR |
2:05 p.m. |
Core 4. Project Management/ Commercialization/ Financing (Core)
Jeffrey Scifert, Senior Engineering Program Manager, Medtronic. |
2:25 p.m. |
Core 5. Designing Pre-/clinical Studies to Drive Clinical Adoption (Core)
Daniel Buser, Professor Emeritus, School of Dental Medicine, University of Bern. |
2:45 p.m. |
ITP 3. Treating of Bone Peri-implantitis/ Implant Placement (ITP)
Tara Aghaloo, Professor of Oral and Maxillofacial Surgery, UCLA School of Dentistry |
3:05 p.m. |
ITP 4. Treating of Bone Periodontitis (ITP)
Charles Sfeir, Director of the Center for Craniofacial Regeneration and Chair of the Department of Periodontics and Preventive Dentistry University of Pittsburgh School of Dental Medicine |
3:25 p.m. |
ITP 5. Regeneration of Soft Tissues (skin, muscles, salivary glands, mucosa, etc.)
Sarah Knox, Assistant Professor Department of Cell & Tissue Biology, UCSF School of Dentistry Chelsea Bahney, Principal Investigator and Program Director/Bone Repair and Skeletal Engineering, The Steadman Clinic & Steadman Philippon Research Institute) |
3:45 p.m. |
Closing Remarks
Jaques Nör, Donald A. Kerr Endowed Professor of Dentistry and Chair of the Department of Cariology, Restorative Sciences and Endodontics, University of Michigan School of Dentistry, Immediate Past President, AADOCR |
Description
2022 Fall Focused Symposium: Session 2
2022 Fall Focused Symposium: Accelerating Translation of Tissue Engineering and Regenerative Medicine Technologies in the Dental, Oral, and Craniofacial Space
There have been significant strides in research in regenerative approaches to the repair and restoration of dental, oral, and craniofacial (DOC) tissues, ranging from bone graft materials to regenerative endodontics to temporomandibular joint repair. Yet few regenerative medicine therapies in the DOC space have been commercialized and widely adopted clinically. Difficulties in translation are related to scientific as well as non-scientific challenges. This symposium will highlight innovative tissue engineering/ regenerative medicine research in the DOC space, as well as layout the roadmap for overcoming challenges and translating technologies to the marketplace.
Learning Objectives
There have been significant strides in research in regenerative approaches to the repair and restoration of dental, oral, and craniofacial (DOC) tissues, ranging from bone graft materials to regenerative endodontics to temporomandibular joint repair. Yet few regenerative medicine therapies in the DOC space have been commercialized and widely adopted clinically. Difficulties in translation are related to scientific as well as non-scientific challenges. This symposium will highlight innovative tissue engineering/ regenerative medicine research in the DOC space, as well as layout the roadmap for overcoming challenges and translating technologies to the marketplace.
Learning Objectives
- Attendees will increase their knowledge of cutting-edge regenerative medicine approaches to a variety of clinical challenges in the DOC space.
- Attendees will increase their understanding of the technology commercialization pathway, from academic research to clinical trials to commercialization and beyond, including regulatory requirements and market development.
- Attendees will be provided with an armamentarium of tools to approach translation of tissue engineering/ regenerative medicine research to the marketplace and beyond.
Time (EST) | Presentation |
---|---|
2:00 p.m. |
Welcome Back Jaques Nör, Donald A. Kerr Endowed Professor of Dentistry and Chair of the Department of Cariology, Restorative Sciences and Endodontics, University of Michigan School of Dentistry, Immediate Past President, AADOCR |
2:05 p.m. |
Project Management/ Commercialization/ Financing (Core)
Kim Martin, Founder and President Boulder Clinical Science and NIH Entrepreneur in Residence |
2:25 p.m. |
Designing Pre-/clinical Studies to Drive Clinical Adoption (Core)
Daniel Buser, Professor Emeritus, School of Dental Medicine, University of Bern. |
2:45 p.m. |
Treating of Bone Peri-implantitis/ Implant Placement (ITP)
Tara Aghaloo, Professor of Oral and Maxillofacial Surgery, UCLA School of Dentistry |
3:05 p.m. |
Treating of Bone Periodontitis (ITP)
Charles Sfeir, Director of the Center for Craniofacial Regeneration and Chair of the Department of Periodontics and Preventive Dentistry University of Pittsburgh School of Dental Medicine |
3:25 p.m. |
Regeneration of Bone (ITP) Yang Chai, University Professor George and MaryLou Boone Chair in Craniofacial Molecular Biology Director, Center for Craniofacial Molecular Biology Associate Dean of Research Ostrow School of Dentistry University of Southern California. |
3:45 p.m. |
Closing Remarks
Jaques Nör, Donald A. Kerr Endowed Professor of Dentistry and Chair of the Department of Cariology, Restorative Sciences and Endodontics, University of Michigan School of Dentistry, Immediate Past President, AADOCR |